par Fumagalli, Debora
;Desmedt, Christine
;Ignatiadis, Michail
;Loi, Sherene
;Piccart-Gebhart, Martine
;Sotiriou, Christos 
Référence Journal of the National Cancer Institute. Monographs, 2011, 43, page (124-127)
Publication Publié, 2011






Référence Journal of the National Cancer Institute. Monographs, 2011, 43, page (124-127)
Publication Publié, 2011
Article révisé par les pairs
Titre: |
|
Auteur: | Fumagalli, Debora; Desmedt, Christine; Ignatiadis, Michail; Loi, Sherene; Piccart-Gebhart, Martine; Sotiriou, Christos |
Informations sur la publication: | Journal of the National Cancer Institute. Monographs, 2011, 43, page (124-127) |
Statut de publication: | Publié, 2011 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Anthracyclines -- therapeutic use |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy -- metabolism | |
Chemotherapy, Adjuvant | |
Female | |
Gene Expression Profiling | |
Gene Expression Regulation, Neoplastic | |
Humans | |
Molecular Targeted Therapy | |
Neoadjuvant Therapy -- methods | |
Predictive Value of Tests | |
Prognosis | |
Randomized Controlled Trials as Topic | |
Tumor Markers, Biological -- metabolism | |
Note générale: | Journal Article |
SCOPUS: ar.k | |
Langue: | Anglais |
Identificateurs: | urn:issn:1052-6773 |
info:doi/10.1093/jncimonographs/lgr040 | |
info:pii/lgr040 | |
info:scp/84855174024 | |
info:pmid/22043058 |